Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $10,000 | 1 | 92.9% |
| Food and Beverage | $763.33 | 41 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $10,000 | 1 | $0 (2022) |
| ABBVIE INC. | $209.28 | 17 | $0 (2024) |
| PFIZER INC. | $146.80 | 7 | $0 (2024) |
| Amgen Inc. | $78.26 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $77.83 | 3 | $0 (2024) |
| Lilly USA, LLC | $53.31 | 3 | $0 (2024) |
| Novo Nordisk Inc | $48.00 | 2 | $0 (2024) |
| Exact Sciences Corporation | $45.58 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $32.93 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $652.17 | 36 | ABBVIE INC. ($209.28) |
| 2023 | $111.16 | 5 | PFIZER INC. ($38.52) |
| 2022 | $10,000 | 1 | Arthrex, Inc. ($10,000) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Oncology | ||||||
| 03/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Obesity | ||||||
| 02/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Biological | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: PAIN | ||||||
| 10/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: PAIN | ||||||
| 09/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 10/27/2022 | Arthrex, Inc. | — | Grant | Cash or cash equivalent | $10,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 44 | $16,190 | $4,002 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $9,750 | $2,435 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $6,440 | $1,567 | 24.3% |
About Christopher Smith
Christopher Smith is a Sports Medicine healthcare provider based in Belmont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1881199909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Smith has received a total of $10,763 in payments from pharmaceutical and medical device companies, with $652.17 received in 2024. These payments were reported across 42 transactions from 12 companies. The most common payment nature is "Grant" ($10,000).
As a Medicare-enrolled provider, Smith has provided services to 41 Medicare beneficiaries, totaling 44 services with total Medicare billing of $4,002. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Belmont, CA
- Active Since 03/29/2018
- Last Updated 12/16/2025
- Taxonomy Code 207QS0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881199909
Products in Payments
- NURTEC ODT (Drug) $123.73
- QULIPTA (Drug) $117.26
- VRAYLAR (Drug) $83.72
- TRELEGY ELLIPTA (Drug) $77.83
- KRYSTEXXA (Biological) $49.83
- Wegovy (Drug) $48.00
- Cologuard Collection Kit (Device) $45.58
- MOUNJARO (Drug) $35.38
- Veozah (Drug) $32.93
- TRINTELLIX (Drug) $32.87
- Otezla (Drug) $28.43
- PAXLOVID (Drug) $23.07
- MYRISK (Device) $22.79
- ZEPBOUND (Drug) $17.93
- DUROLANE (Device) $15.68
- UBRELVY (Drug) $8.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.